nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An infectious narrative
|
Burki, Talha Khan |
|
2014 |
2 |
4 |
p. 266- 1 p. |
artikel |
2 |
Antibiotics for respiratory infections: too much, too soon
|
Burki, Talha Khan |
|
2014 |
2 |
4 |
p. 262- 1 p. |
artikel |
3 |
Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study
|
Walker, Timothy M |
|
2014 |
2 |
4 |
p. 285-292 8 p. |
artikel |
4 |
Child health and tuberculosis
|
Marais, Ben J |
|
2014 |
2 |
4 |
p. 254-256 3 p. |
artikel |
5 |
Corrections
|
|
|
2014 |
2 |
4 |
p. e4- 1 p. |
artikel |
6 |
Corrections
|
|
|
2014 |
2 |
4 |
p. e4- 1 p. |
artikel |
7 |
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
|
Raghu, Ganesh |
|
2014 |
2 |
4 |
p. 277-284 8 p. |
artikel |
8 |
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
|
Dheda, Keertan |
|
2014 |
2 |
4 |
p. 321-338 18 p. |
artikel |
9 |
MMR lowers infection-related hospital admissions in children
|
Tanday, Sanjay |
|
2014 |
2 |
4 |
p. 263- 1 p. |
artikel |
10 |
Moving beyond “me-too” respiratory drugs
|
Furlow, Bryant |
|
2014 |
2 |
4 |
p. 261- 1 p. |
artikel |
11 |
N-acetylcysteine for COPD: the evidence remains inconclusive
|
Turner, Richard D |
|
2014 |
2 |
4 |
p. e3- 1 p. |
artikel |
12 |
N-acetylcysteine for COPD: the evidence remains inconclusive – Authors' reply
|
Zheng, Jin-Ping |
|
2014 |
2 |
4 |
p. e3-e4 nvt p. |
artikel |
13 |
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
|
Jones, Rupert C M |
|
2014 |
2 |
4 |
p. 267-276 10 p. |
artikel |
14 |
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
|
Kaufmann, Stefan H E |
|
2014 |
2 |
4 |
p. 301-320 20 p. |
artikel |
15 |
Pulmonary hypertension of sickle cell disease: new guidelines
|
Furlow, Bryant |
|
2014 |
2 |
4 |
p. 263- 1 p. |
artikel |
16 |
Respiratory medicine and critical care: a call for papers
|
Godsland, Jane |
|
2014 |
2 |
4 |
p. 260- 1 p. |
artikel |
17 |
Robert Heinrich Herman Koch
|
Akkermans, Rebecca |
|
2014 |
2 |
4 |
p. 264-265 2 p. |
artikel |
18 |
Should we pursue pulmonary vasodilation in patients with COPD?
|
Brusselle, Guy |
|
2014 |
2 |
4 |
p. 252-254 3 p. |
artikel |
19 |
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
|
Goudie, Andrew R |
|
2014 |
2 |
4 |
p. 293-300 8 p. |
artikel |
20 |
The evolving role of advocacy in tuberculosis
|
DeLuca, Andrea |
|
2014 |
2 |
4 |
p. 258-259 2 p. |
artikel |
21 |
The lung and winding road
|
The Lancet Respiratory Medicine, |
|
2014 |
2 |
4 |
p. 247- 1 p. |
artikel |
22 |
Totally-drug-resistant tuberculosis: hype versus hope
|
Maeurer, Markus |
|
2014 |
2 |
4 |
p. 256-257 2 p. |
artikel |
23 |
Towards earlier diagnosis of COPD
|
van Weel, Chris |
|
2014 |
2 |
4 |
p. 248-249 2 p. |
artikel |
24 |
Tracking the history of influenza
|
van Dorn, Aaron |
|
2014 |
2 |
4 |
p. 265- 1 p. |
artikel |
25 |
Understanding CT patterns in idiopathic pulmonary fibrosis
|
Hart, Simon P |
|
2014 |
2 |
4 |
p. 249-250 2 p. |
artikel |
26 |
Use of interferon beta for acute respiratory distress syndrome: proceed with caution
|
George, Peter M |
|
2014 |
2 |
4 |
p. e2- 1 p. |
artikel |
27 |
Use of interferon beta for acute respiratory distress syndrome: proceed with caution – Authors' reply
|
Bellingan, Geoff |
|
2014 |
2 |
4 |
p. e2-e3 nvt p. |
artikel |
28 |
Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological marker
|
van Soolingen, Dick |
|
2014 |
2 |
4 |
p. 251-252 2 p. |
artikel |